Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Delluc

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Revue Des Maladies Respiratoires|March 13, 2012
[Epidemiology and risk factors of venous thromboembolism]A Delluc, F Le Ven, D Mottier, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2009
Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control studyA Delluc, D Mottier, G Le Gal, et al.
Revue Des Maladies Respiratoires|March 21, 2021
[Which aetiological investigations to undertake during the progress of PE/DVT?]Y Benhamou, A Delluc, L Mauge, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?P Cacoub, A Delluc, D Saadoun, et al.
Revue Des Maladies Respiratoires|October 16, 2019
[What route of care to propose to patients suffering from pulmonary embolism ? Who to treat as an outpatient ?]L Bertoletti, A Delluc, P Frappé, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2017
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTHA Delluc, D Antic, R Lecumberri, et al.
La Revue De Medecine Interne|February 3, 2016
[Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?]C de Moreuil, J-C Ianotto, J-R Eveillard, et al.
Annals of the Rheumatic Diseases|January 15, 2008
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndromeA Delluc, N Limal, X Puéchal, et al.
Fundamental & Clinical Pharmacology|August 19, 2009
Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control studyF Z Belattar, A Delluc, G Le Gal, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disordersB Terrier, D Sène, D Saadoun, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Revue Des Maladies Respiratoires|March 13, 2012
[Epidemiology and risk factors of venous thromboembolism]A Delluc, F Le Ven, D Mottier, et al.
Journal of Thrombosis and Haemostasis : JTH|February 5, 2009
Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control studyA Delluc, D Mottier, G Le Gal, et al.
Revue Des Maladies Respiratoires|March 21, 2021
[Which aetiological investigations to undertake during the progress of PE/DVT?]Y Benhamou, A Delluc, L Mauge, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?P Cacoub, A Delluc, D Saadoun, et al.
Revue Des Maladies Respiratoires|October 16, 2019
[What route of care to propose to patients suffering from pulmonary embolism ? Who to treat as an outpatient ?]L Bertoletti, A Delluc, P Frappé, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2017
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTHA Delluc, D Antic, R Lecumberri, et al.
La Revue De Medecine Interne|February 3, 2016
[Multiple myeloma and venous thrombosis. Which thromboprophylaxis should be given?]C de Moreuil, J-C Ianotto, J-R Eveillard, et al.
Annals of the Rheumatic Diseases|January 15, 2008
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndromeA Delluc, N Limal, X Puéchal, et al.
Fundamental & Clinical Pharmacology|August 19, 2009
Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control studyF Z Belattar, A Delluc, G Le Gal, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disordersB Terrier, D Sène, D Saadoun, et al.
Pageof 4